Whole-genome sequencing reveals highly specific gene targeting by in vitro assembled Cas9-ribonucleoprotein complexes in Aspergillus fumigatus
- PMID: 29992034
- PMCID: PMC5987418
- DOI: 10.1186/s40694-018-0057-2
Whole-genome sequencing reveals highly specific gene targeting by in vitro assembled Cas9-ribonucleoprotein complexes in Aspergillus fumigatus
Abstract
Background: CRISPR/Cas9-based genome editing is quickly becoming a powerful tool within the field of fungal genetics. Adaptation of CRISPR/Cas9 systems are allowing for rapid and highly efficient gene targeting within fungi. We recently reported the adaptation of a simple CRISPR/Cas9 system for gene deletion that is effective across multiple genetic backgrounds of Aspergillus fumigatus. This system employs in vitro assembly of Cas9 ribonucleoproteins (RNPs) coupled with micro-homology repair templates for gene deletion. Although highly efficient at gene targeting in wild type genetic backgrounds of A. fumigatus, the potential for our system to produce unwanted off-target mutations has not been addressed.
Results: Next-generation Illumina sequencing was used to identify genome mutations among transformants isolated from standard (no Cas9) and Cas9-mediated integration of a hygromycin deletion cassette. Two different concentrations of Cas9 were utilized to examine the association of Cas9 concentration with total numbers and types of genomic mutations. For each of the three test groups (zero, low, and high Cas9), three transformants were sequenced and compared to the parent strain. Bioinformatics analyses revealed the average number of total mutations to be similar among all three test groups. A. fumigatus transformation using standard, non-Cas9-mediated methods resulted in an average of 373 ± 28 mutations. In comparison, transformation with in vitro assembled Cas9-RNPs using either high (1 µg/µl) or low (0.5 µg/µl) levels of Cas9 resulted in an average of 326 ± 19 and 395 ± 69 mutations, respectively. In all cases, the vast majority of mutations identified were intergenic. No correlation between the amount of Cas9 utilized for transformation and the overall number of mutations was found. Finally, the specific type of mutation introduced during the transformation process was not Cas9-dependent, as both single-nucleotide polymorphisms and insertion/deletion events were not significantly different between the experimental groups.
Conclusions: CRISPR/Cas9-based genome editing in A. fumigatus using in vitro assembled RNPs coupled with microhomology templates is a reliable method of gene targeting. This system is highly efficient and is not associated with increased off-target mutations caused by introduction of the Cas9 nuclease.
Keywords: Aspergillus fumigatus; CRISPR/Cas9; Genome editing; Off-target mutation.
Figures

Similar articles
-
A Simple and Universal System for Gene Manipulation in Aspergillus fumigatus: In Vitro-Assembled Cas9-Guide RNA Ribonucleoproteins Coupled with Microhomology Repair Templates.mSphere. 2017 Nov 22;2(6):e00446-17. doi: 10.1128/mSphere.00446-17. eCollection 2017 Nov-Dec. mSphere. 2017. PMID: 29202040 Free PMC article.
-
A Simple CRISPR/Cas9 System for Efficiently Targeting Genes of Aspergillus Section Flavi Species, Aspergillus nidulans, Aspergillus fumigatus, Aspergillus terreus, and Aspergillus niger.Microbiol Spectr. 2023 Feb 14;11(1):e0464822. doi: 10.1128/spectrum.04648-22. Epub 2023 Jan 18. Microbiol Spectr. 2023. PMID: 36651760 Free PMC article.
-
Rapid Hypothesis Testing in Candida albicans Clinical Isolates Using a Cloning-Free, Modular, and Recyclable System for CRISPR-Cas9 Mediated Mutant and Revertant Construction.Microbiol Spectr. 2022 Jun 29;10(3):e0263021. doi: 10.1128/spectrum.02630-21. Epub 2022 May 25. Microbiol Spectr. 2022. PMID: 35612314 Free PMC article.
-
CRISPR/Cas9; A robust technology for producing genetically engineered plants.Cell Mol Biol (Noisy-le-grand). 2018 Nov 30;64(14):31-38. Cell Mol Biol (Noisy-le-grand). 2018. PMID: 30511631 Review.
-
Gene Editing in Clinical Practice: Where are We?Indian J Clin Biochem. 2019 Jan;34(1):19-25. doi: 10.1007/s12291-018-0804-4. Epub 2019 Jan 1. Indian J Clin Biochem. 2019. PMID: 30728669 Free PMC article. Review.
Cited by
-
Non-homologous end-joining-deficient filamentous fungal strains mitigate the impact of off-target mutations during the application of CRISPR/Cas9.mBio. 2023 Aug 31;14(4):e0066823. doi: 10.1128/mbio.00668-23. Epub 2023 Jul 24. mBio. 2023. PMID: 37486124 Free PMC article.
-
A secondary mechanism of action for triazole antifungals in Aspergillus fumigatus mediated by hmg1.Nat Commun. 2024 Apr 29;15(1):3642. doi: 10.1038/s41467-024-48029-2. Nat Commun. 2024. PMID: 38684680 Free PMC article.
-
Development of a marker-free mutagenesis system using CRISPR-Cas9 in the pathogenic mould Aspergillus fumigatus.Fungal Genet Biol. 2020 Dec;145:103479. doi: 10.1016/j.fgb.2020.103479. Epub 2020 Oct 26. Fungal Genet Biol. 2020. PMID: 33122116 Free PMC article.
-
The CRISPR revolution in fungal biology and biotechnology, and beyond.Fungal Biol Biotechnol. 2018 Dec 20;5:19. doi: 10.1186/s40694-018-0064-3. eCollection 2018. Fungal Biol Biotechnol. 2018. PMID: 30598829 Free PMC article. No abstract available.
-
A user-friendly CRISPR/Cas9 system for mutagenesis of Neurospora crassa.Sci Rep. 2024 Sep 3;14(1):20469. doi: 10.1038/s41598-024-71540-x. Sci Rep. 2024. PMID: 39227671 Free PMC article.
References
-
- da Silva Ferreira ME, Kress MRVZ, Savoldi M, Goldman MHS, Härtl A, Heinekamp T, Brakhage AA, Goldman GH. The akuBKU80 mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus. Eukaryot Cell. 2006;5:207–211. doi: 10.1128/EC.5.1.207-211.2006. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources